Next Science's XPERIENCE No Rinse Antimicrobial Solution Cleared by FDA for Sale in USA
Next Science’s XPERIENCE No Rinse Antimicrobial Solution Cleared by FDA for Sale in USA Highlights XPERIENCE meets large unmet need – market leading performance in reduction of all tested pathogens Commercial sales in the USA to commence immediately $15B per annum total addressable market SYDNEY--(BUSINESS WIRE)--Next Science Limited (ASX:NXS) ( Next Science / Company) is pleased to announce that it has received a section 510(k) clearance from the Food and Drug Administration (FDA) for the sale of XPERIENCE No Rinse Antimicrobial Solution as a medical device in the United States. Sales of...